Owlet (OWLT) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
14 Aug, 2026Executive summary
Achieved record Q2 2026 revenue of $33.9 million, up 29.9% year-over-year, driven by strong Dream Sock, Dream Duo, international, and subscription growth.
Subscription revenue reached $3.2 million, up $2.4 million year-over-year, with 130,000 paying subscribers and strong international and platform growth.
Transitioned toward a data and services platform, expanding product and subscription offerings, and rolling out telehealth and web-based enrollment.
Net loss narrowed significantly to $0.6 million for Q2 2026, or $4.4 million excluding the $3.75 million tariff refund, compared to $37.4 million loss in Q2 2025.
Set new market share record and maintained focus on expanding the subscriber base and international scaling.
Financial highlights
Q2 2026 revenue was $33.9 million, up 29.9% year-over-year; hardware revenue grew 21.6% and subscription revenue rose 273.1%.
Q2 gross margin was 64.4%; excluding a $3.5 million tariff refund, gross margin was 54.0%, up 270 basis points year-over-year.
Adjusted EBITDA reached $2.9 million excluding the tariff refund, and $6.7 million including it.
Operating expenses rose to $20.1 million, mainly due to higher marketing spend, severance, and stock-based compensation.
Cash and cash equivalents were $30.9 million at quarter-end.
Outlook and guidance
Full-year 2026 revenue guidance remains $118–$122 million.
Gross margin guidance raised to 53%–55% (from 50%–52%), reflecting the one-time tariff refund.
Adjusted EBITDA guidance increased to $10.75 million–$12.75 million (from $7 million–$9 million), reflecting the one-time benefit.
Q3 expected to decline sequentially and year-over-year due to competitor discounting and tough comps; Q4 forecast maintained.
Management expects existing cash, cash equivalents, and borrowing capacity to be sufficient for at least the next 12 months.
Latest events from Owlet
- All proposals, including director elections and plan amendments, were approved by stockholders.OWLT
AGM 2026 - Strong retail, international, and medical channel growth, with digital health and subscription expansion.OWLT
TD Cowen 45th Annual Healthcare Conference - Virtual annual meeting to vote on directors, pay, auditor, and incentive plan amendment.OWLT
Proxy filing - Shareholders will vote on director elections, executive pay, auditor ratification, and an expanded incentive plan.OWLT
Proxy filing - Subscription growth, telehealth launch, and AI-driven efficiency drive profitability and focus.OWLT
46th Annual William Blair Growth Stock Conference - Subscription and AI-driven health insights fuel growth, with FDA clearance as a key differentiator.OWLT
TD Cowen 10th Annual Future of the Consumer Conference - Q1 2026 revenue up 6.4% to $22.5M, with record subscriptions and improved margins.OWLT
Q1 2026 - Record revenue and FDA-cleared status drive growth in pediatric health monitoring.OWLT
Investor presentation - Up to 9.6 million shares registered for resale by major holders; no proceeds to the company.OWLT
Registration Filing